Mechanical Partitioning of mTORC2 to Direct Mesenchymal Stem Cell Fate

mTORC2 的机械分区指导间充质干细胞的命运

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Spatial, chemical, and mechanical signals all contribute to lineage allocation of pluripotent mesenchymal stem cells (MSCs). When the fate of MSCs tips in favor of adipogenesis and away from osteogenesis in conditions such as unloading, aging, or estrogen deficiency, bone quality is diminished and risk of fracture increases. Dynamic skeletal loading inhibits adipogenesis in vitro and in vivo by enhancing β-catenin activity in MSCs. MSC potential is preserved by a signaling pathway, which is initiated at focal adhesions (FAs) setting off a cascade of ↑Fyn/FAK to ↑mTORC2 to ↑Akt to ↓GSK3β and ↑β-catenin. We have shown that mechanical strain recruits mTORC2 and Akt to FAs; however, the mechanisms responsible for this intracellular signal partitioning and the specific activation sites of mTORC2 subunits are unknown. Preliminary work suggests that strain induces an association of mTORC2 with myosin motors. Just as other intracellular "cargo", including β- integrins, attach to myosins to be transported to FAs, myosins may enable recruitment of mTORC2 to FAs in response to mechanical force. We have also shown that Fyn and mTORC2/Akt participate in mechanically regulated activation of RhoA; however, preliminary work suggests that GEF or GAP intermediaries may be required for RhoA-induced cytoskeletal reorganization and adipogenic repression. The focus of this proposal will be to examine the regulatory modifications of mTORC2-specific subunits and to determine how strain recruits mTORC2 to FAs to be activated. Additionally, we will ask how mTORC2/Akt regulate GEF and GAP RhoA effectors to auto-regulate the cytoskeleton in response to physical force. The proposed hypotheses will be examined through the following specific aims: 1) determine how mTORC2 is activated by mechanical strain; 2) identify mechanisms by which mTORC2 regulates cytoskeletal reorganization. Pharmacological inhibition/knockdown studies will be performed using primary marrow-derived MSCs to examine myosin- mediated mTORC2 FA recruitment, to identify mechanically responsive phosphorylation sites on mTORC2 subunits, and to determine how these modifications influence cytoskeletal remodeling. Additionally, RhoA, GEF, and GAP pull down assays will be employed to study the effects of force on modulators of cytoskeletal adaptation. These studies have implications for understanding the mechanisms by which mechanical loading regulates cytoskeletal assembly and reinforcement, a process essential for proper regulation of mechanosensation and MSC lineage fate. As such, this work will inform the design of future strategies for using exercise to affect development of fat and bone.
 描述(由应用提供):空间,化学和机械信号都有助于多能间充质干细胞(MSC)的谱系分配。当MSC的命运提示支持脂肪形成并在诸如卸载,衰老或雌激素缺乏症等条件下脱离成骨时,骨骼质量会降低,骨折风险增加。动态骨骼负荷通过增强MSC中的β-catenin活性在体外和体内抑制脂肪形成。 MSC电势由信号通路保留,该信号通路是在焦点广告(FAS)启动的,将↑fyn/fak的级联启动至↑mtorc2至↑AKT至↓GSK3β和↑β-catenin。我们已经表明,机械应变将MTORC2和AKT募集到FAS。但是,造成这种细胞内信号分配和MTORC2亚基的特定激活位点的机制尚不清楚。初步工作表明,菌株诱导MTORC2与肌球蛋白电机的关联。就像其他细胞内“货物”(包括β-积聚蛋白)附着于要运输到FAS上的肌动物一样,肌动蛋白也可以使MTORC2募集到FAS上,以响应机械力。我们还表明,FYN和MTORC2/AKT参与了RhoA的机械调节激活。但是,初步工作表明,RhoA诱导的细胞骨架重组和成脂性表达可能需要GEF或GAP中间体。该提案的重点是检查MTORC2特异性亚基的调节修改,并确定应变如何将MTORC2募集到FAS中被激活。此外,我们将询问MTORC2/AKT如何调节GEF和GAP RHOA效应以自动调节响应物理力的细胞骨架。提出的假设将通过以下特定目的进行检查:1)确定MTORC2如何通过机械应变激活; 2)确定MTORC2调节细胞骨架重组的机制。将使用原代骨髓衍生的MSC进行药理抑制/敲低研究,以检查肌球蛋白介导的MTORC2 FA募集,以鉴定MTORC2亚基上机械响应的磷酸化位点,并确定这些修饰如何影响细胞骨架重塑。此外,将采用RhoA,GEF和GAP下拉测定法研究力对细胞骨架适应调节剂的影响。这些研究对理解机械载荷调节细胞骨架组装和增强的机制具有影响,这对于正确调节机理敏感性和MSC谱系命运至关重要。因此,这项工作将为未来使用运动影响脂肪和骨骼发育的策略的设计提供信息。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Differential Iron Requirements for Osteoblast and Adipocyte Differentiation.
  • DOI:
    10.1002/jbm4.10529
  • 发表时间:
    2021-09
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Edwards DF 3rd;Miller CJ;Quintana-Martinez A;Wright CS;Prideaux M;Atkins GJ;Thompson WR;Clinkenbeard EL
  • 通讯作者:
    Clinkenbeard EL
Skeletal Functions of Voltage Sensitive Calcium Channels.
  • DOI:
    10.1007/s11914-020-00647-7
  • 发表时间:
    2021-04
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
    Wright CS;Robling AG;Farach-Carson MC;Thompson WR
  • 通讯作者:
    Thompson WR
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William Roy Thompson其他文献

William Roy Thompson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William Roy Thompson', 18)}}的其他基金

Osteocyte Mechanotransduction and the Gabapentin-Sensitive Matrix-Channel Tethering Complex
骨细胞机械转导和加巴喷丁敏感基质通道束缚复合物
  • 批准号:
    10428360
  • 财政年份:
    2018
  • 资助金额:
    $ 46.64万
  • 项目类别:
Osteocyte Mechanotransduction and the Gabapentin-Sensitive Matrix-Channel Tethering Complex
骨细胞机械转导和加巴喷丁敏感基质通道束缚复合物
  • 批准号:
    10192665
  • 财政年份:
    2018
  • 资助金额:
    $ 46.64万
  • 项目类别:
Osteocyte Mechanotransduction and the Gabapentin-Sensitive Matrix-Channel Tethering Complex
骨细胞机械转导和加巴喷丁敏感基质通道束缚复合物
  • 批准号:
    9789654
  • 财政年份:
    2018
  • 资助金额:
    $ 46.64万
  • 项目类别:
Role of mechanically activated Src/mTORC2 signaling on cytoskeletal adaptation
机械激活的 Src/mTORC2 信号对细胞骨架适应的作用
  • 批准号:
    8457722
  • 财政年份:
    2013
  • 资助金额:
    $ 46.64万
  • 项目类别:
Role of mechanically activated Src/mTORC2 signaling on cytoskeletal adaptation
机械激活的 Src/mTORC2 信号对细胞骨架适应的作用
  • 批准号:
    8601625
  • 财政年份:
    2013
  • 资助金额:
    $ 46.64万
  • 项目类别:

相似国自然基金

脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
  • 批准号:
    82301753
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肝细胞因子ORM2通过抑制Kupffer细胞激活改善非酒精性脂肪性肝炎的作用及机制研究
  • 批准号:
    82300966
  • 批准年份:
    2023
  • 资助金额:
    20 万元
  • 项目类别:
    青年科学基金项目
CD36/FABP4/CPT1轴介导脂肪酸转运促进白血病干细胞的维持在白血病化疗耐药中的作用及机制研究
  • 批准号:
    82300206
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
放射后早期神经元-星形胶质细胞脂肪酸代谢耦联对正常脑组织免疫微环境的重塑及其机制研究
  • 批准号:
    82373516
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
高原低氧上调肝脏ANGPTL4基因的表达导致巨噬细胞M1/M2比例失衡从而促进肝脂肪化的机制研究
  • 批准号:
    82360333
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Advanced Knee ASL Imaging at 7T
7T 先进膝关节 ASL 成像
  • 批准号:
    10658674
  • 财政年份:
    2023
  • 资助金额:
    $ 46.64万
  • 项目类别:
Household Air Pollution, Adiposity, and Cardiorenal Disease Risk in Children
家庭空气污染、肥胖和儿童心肾疾病风险
  • 批准号:
    10739062
  • 财政年份:
    2023
  • 资助金额:
    $ 46.64万
  • 项目类别:
Cell cycle control of adipogenesis
脂肪生成的细胞周期控制
  • 批准号:
    10668721
  • 财政年份:
    2023
  • 资助金额:
    $ 46.64万
  • 项目类别:
Identifying interconnections of the disparities in childhood obesity
确定儿童肥胖差异之间的相互关系
  • 批准号:
    10654256
  • 财政年份:
    2023
  • 资助金额:
    $ 46.64万
  • 项目类别:
Skeletal Health and Bone Marrow Composition in Adolescents with Crohn’s Disease
患有克罗恩病的青少年的骨骼健康和骨髓成分
  • 批准号:
    10740272
  • 财政年份:
    2023
  • 资助金额:
    $ 46.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了